tiprankstipranks
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
India Market
SPARC
Sun Pharma Advanced Research Co. Ltd.
RESEARCH TOOLSreports
Want to see IN:SPARC full AI Analyst Report?

Sun Pharma Advanced Research Co. Ltd. (SPARC) Income Statement

7 Followers

Sun Pharma Advanced Research Co. Ltd. Income Statement

Last quarter (Q2 2026), Sun Pharma Advanced Research Co. Ltd.'s total revenue was ₹78.60M, a decrease of -38.88% from the same quarter last year. In Q2, Sun Pharma Advanced Research Co. Ltd.'s net income was ₹-758.50M. See Sun Pharma Advanced Research Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 18.79B₹ 717.70M₹ 755.45M₹ 2.39B₹ 1.37B
Gross Profit
₹ 17.27B₹ 486.50M₹ -1.24B₹ 821.21M₹ 105.52M
Operating Expenses
₹ 1.39B₹ 3.27B₹ 7.74B₹ 3.06B₹ 4.90B
Depreciation and Amortization
₹ 102.10M₹ 123.90M₹ 125.11M₹ 117.71M₹ 101.62M
EBITDA
₹ 15.99B₹ -3.23B₹ -3.73B₹ -2.03B₹ -1.80B
Operating Income
₹ 15.89B₹ -2.78B₹ -4.12B₹ -2.24B₹ -1.97B
Other Income/Expenses
₹ -355.40M₹ -648.00M₹ 246.72M₹ 10.61M₹ -73.23M
Pretax Income
₹ 15.53B₹ -3.43B₹ -3.87B₹ -2.23B₹ -2.03B
Net Income
₹ 15.53B₹ -3.43B₹ -3.87B₹ -2.23B₹ -2.03B
Per Share Metrics
Basic EPS
₹ 47.86₹ -10.55₹ -11.93₹ -7.82₹ -7.73
Diluted EPS
₹ 47.86₹ -10.55₹ -11.93₹ -7.82₹ -7.73
Weighted Average Shares Outstanding
 324.53M 324.65M 324.57M 284.70M 263.14M
Weighted Average Shares Outstanding (Diluted)
 324.53M 324.65M 324.52M 284.70M 263.14M
Currency in INR

Sun Pharma Advanced Research Co. Ltd. Earnings and Revenue History